Effect of ACE gene polymorphism on age at renal death in polycystic kidney disease in Japan

American Journal of Kidney Diseases

Volumn 37, Issue 1, 2001, Pages 113-118

  Konoshita, Tadashi ^a,b   Miyagi, Kyoko ^a,b   Onoe, Tamehito ^a,b   Katano, Kenichi ^a,b   Mutoh, Hisao ^a,b   Nomura, Hideki ^a,b   Koni, Ichiro ^a,b   Miyamori, Isamu ^a,b   Mabuchi, Hiroshi ^a,b  

^a UNIVERSITY OF FUKUI   (Japan)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme (ACE) gene polymorphism; End stage renal disease (ESRD); Polycystic kidney disease (PKD)

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEMODIALYSIS; HOMOZYGOSITY; HUMAN; JAPAN; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0035164795     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.20595     Document Type: Article

References (33)

1. Autosomal dominant polycystic kidney disease
2. Clinical characteristics of polycystic kidney disease with end-stage renal disease
3. The European Polycystic Kidney Disease Consortium: The polycystic kidney disease 1 gene encodes a 14-kb transcript and lies within a duplicated region on chromosome 16
4. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein
5. Identification of PKDL, a novel polycystic kidney disease 2-like gene whose murine homologue is deleted in mice with kidney and retinal defects
6. The diagnosis and prognosis of autosomal dominant polycystic kidney disease
7. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2
8. The anatomy of the renin-secreting cell in adult polycystic kidney disease
9. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease
10. Molecular basis of human hypertension: Role of angiotensinogen
11. Linkage of the angiotensinogen gene to essential hypertension
12. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension
13. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
14. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction
15. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications
16. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus
17. Angiotensin-converting enzyme gene and diabetes mellitus
18. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy
19. Role of the deletion of polymorphism of the angiotensin-converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy
20. Angiotensin-converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy
21. Association of angiotensinogen gene T235 variant with progression of immunoglobulinin A nephropathy in Caucasian patients
22. Molecular genetic investigations in autosomal dominant polycystic kidney disease. Gene mutation detection, linkage analysis, and preliminary ACE gene I/D polymorphism association studies: An update
23. Association between angiotensin-converting enzyme gene polymorphism and clinical features in autosomal dominant polycystic kidney disease
24. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease
25. Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease
26. Evaluation of ultrasono-graphic diagnostic criteria for autosomal dominant polycystic kidney disease 1
27. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)
28. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease
29. Angiotensin-converting enzyme gene polymorphism in haemodialysis patients
30. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
31. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme
32. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis
33. Effect of deletion polymorphism of angiotensin-converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin-converting enzyme: Observational follow up study